Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells.
about
The clinical value of lncRNA NEAT1 in digestive system malignancies: A comprehensive investigation based on 57 microarray and RNA-seq datasets.Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/β-catenin signaling pathway.Genomic profiling of long non-coding RNA and mRNA expression associated with acquired temozolomide resistance in glioblastoma cells.Long non-coding RNA AK058003, as a precursor of miR-15a, interacts with HuR to inhibit the expression of γ-synuclein in hepatocellular carcinoma cells.Inhibition of long non-coding RNA UCA1 by CRISPR/Cas9 attenuated malignant phenotypes of bladder cancer.Genome-wide analysis of differentially expressed lncRNAs and mRNAs in primary gonadotrophin adenomas by RNA-seqCorrelation of long non-coding RNA H19 expression with cisplatin-resistance and clinical outcome in lung adenocarcinoma.Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.Genome-wide profiling of micro-RNA expression in gefitinib-resistant human lung adenocarcinoma using microarray for the identification of miR-149-5p modulation.LncRNA XIST Promotes Pancreatic Cancer Proliferation Through miR-133a/EGFR.Identification of long non-coding RNAs that stimulate cell survival in bladder cancer.Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells.WP1130 attenuates cisplatin resistance by decreasing P53 expression in non-small cell lung carcinomas.Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1.LncRNA UCA1 in anti-cancer drug resistance.LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1.LncRNA-UCA1 enhances MMP-13 expression by inhibiting miR-204-5p in human chondrocytes.LncRNA SNHG12 contributes to multidrug resistance through activating the MAPK/Slug pathway by sponging miR-181a in non-small cell lung cancer.Aberrant Long Noncoding RNAs Expression Profiles Affect Cisplatin Resistance in Lung Adenocarcinoma.Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer.lncRNA SNHG5 is associated with poor prognosis of bladder cancer and promotes bladder cancer cell proliferation through targeting p27.BMP9 Promotes the Proliferation and Migration of Bladder Cancer Cells through Up-Regulating lncRNA UCA1.Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.Exosomes in Cancer Liquid Biopsy: A Focus on Breast Cancer.Emerging role of long non-coding RNAs in cisplatin resistance.Long non-coding RNAs AC026904.1 and UCA1: a "one-two punch" for TGF-β-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer.Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast CancerNon-coding RNA NEAT1/miR-214-3p contribute to doxorubicin resistance of urothelial bladder cancer preliminary through the Wnt/β-catenin pathwayThe Network of Non-coding RNAs in Cancer Drug ResistancemiRNAs and lncRNAs as Predictive Biomarkers of Response to FOLFOX Therapy in Colorectal CancerLong non-coding RNA DANCR promotes malignant phenotypes of bladder cancer cells by modulating the miR-149/MSI2 axis as a ceRNA
P2860
Q33566616-6F4972CF-3D4E-47E9-B7F9-06BE03D13AE8Q33566847-9DEB0D55-C579-4AA9-A2BB-C29AB67CE100Q33893229-06C18A4C-B0F1-440C-AEB4-8A8BF5B86AE0Q37705985-32979D94-9ADC-4537-94C2-BF5AD501AAAEQ37706034-0919873D-0225-4846-AEC1-131F55F43D20Q37706227-4F7E1175-A370-4679-91C8-577922D7F148Q37709328-F640F753-094C-4018-9B27-45ACC117E9C2Q38546133-CBCDF885-052C-48D8-97E2-56696B38D22FQ38710426-70A64596-28B9-4624-AFC0-DD718D47B384Q38745036-1EBD2F1D-3525-452F-ACA5-A718372D5A2FQ38834015-B8F6C147-FF3A-4729-9534-E6647E164E42Q39254523-E848B3AF-7FDF-4721-B155-5DAB8581A15BQ40236002-D9CFF855-16BC-4E90-8E28-D064372A2504Q41542110-51DE8A00-1030-4EDC-9A36-A734258C82D4Q42362804-012EBEE4-A8C4-4527-B7EB-5D5C67BA8BBEQ42654010-C8A672D7-2D2E-4CB4-8104-87E82C51C7FEQ47144481-A645437C-C3E6-497F-9060-6DF2A524D39AQ47159016-4F873B1B-DF1D-4FB2-96F2-03F05C685D53Q48346788-09F0B6E7-3503-42AD-B6F2-3BF73EA79F76Q49164867-0A625C90-6342-433C-AA7B-73161288CAD6Q49880961-6810749E-2051-4C1D-B1AF-6CBD52CB26DCQ52593632-A79A7255-C12D-4F6F-97C6-B51E06B1150AQ52597053-BA48F1F0-D402-4006-987E-D0A8428617E5Q52676618-D8A468A5-1E6E-41A5-AD1C-7C85DFF7D4D3Q55172138-EDB38ADA-60C5-4373-9987-DC2DB29CDE69Q55520034-2C751164-05C3-427F-A118-1E9161E9ACBBQ57106074-25F3A19F-174C-45D4-B18E-502D00F98AFAQ57815805-3A3116A6-8728-43DE-9BF7-88097D480926Q58694197-F83521F7-2F66-419C-922E-DBCCD49C8A97Q58799032-9519E1C8-4544-4C1E-B64E-A01FC7835D0EQ59127295-B905BD04-B3EF-4236-A2ED-B8B0A16126A3
P2860
Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Long non-coding RNA UCA1 promo ...... 6a-5p in bladder cancer cells.
@en
type
label
Long non-coding RNA UCA1 promo ...... 6a-5p in bladder cancer cells.
@en
prefLabel
Long non-coding RNA UCA1 promo ...... 6a-5p in bladder cancer cells.
@en
P2093
P1433
P1476
Long non-coding RNA UCA1 promo ...... 6a-5p in bladder cancer cells.
@en
P2093
Huilian Hou
Jingjing Pan
Wenjing Wu
P356
10.1016/J.CANLET.2016.08.015
P407
P577
2016-08-31T00:00:00Z